These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

283 related items for PubMed ID: 17550216

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. (Ultra-)long-acting insulin analogues versus NPH insulin (human isophane insulin) for adults with type 2 diabetes mellitus.
    Semlitsch T, Engler J, Siebenhofer A, Jeitler K, Berghold A, Horvath K.
    Cochrane Database Syst Rev; 2020 Nov 09; 11(11):CD005613. PubMed ID: 33166419
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. (Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus.
    Hemmingsen B, Metzendorf MI, Richter B.
    Cochrane Database Syst Rev; 2021 Mar 04; 3(3):CD013498. PubMed ID: 33662147
    [Abstract] [Full Text] [Related]

  • 7. Lower fasting blood glucose, glucose variability and nocturnal hypoglycaemia with glargine vs NPH basal insulin in subjects with Type 1 diabetes.
    Bolli GB, Songini M, Trovati M, Del Prato S, Ghirlanda G, Cordera R, Trevisan R, Riccardi G, Noacco C.
    Nutr Metab Cardiovasc Dis; 2009 Oct 04; 19(8):571-9. PubMed ID: 18676131
    [Abstract] [Full Text] [Related]

  • 8. Systematic review and economic evaluation of a long-acting insulin analogue, insulin glargine.
    Warren E, Weatherley-Jones E, Chilcott J, Beverley C.
    Health Technol Assess; 2004 Nov 04; 8(45):iii, 1-57. PubMed ID: 15525480
    [Abstract] [Full Text] [Related]

  • 9. A randomized trial comparing the rate of hypoglycemia--assessed using continuous glucose monitoring--in 125 preschool children with type 1 diabetes treated with insulin glargine or NPH insulin (the PRESCHOOL study).
    Danne T, Philotheou A, Goldman D, Guo X, Ping L, Cali A, Johnston P.
    Pediatr Diabetes; 2013 Dec 04; 14(8):593-601. PubMed ID: 23730996
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Insulin glargine improves glycemic control and quality of life in type 2 diabetic patients on hemodialysis.
    Toyoda M, Kimura M, Yamamoto N, Miyauchi M, Umezono T, Suzuki D.
    J Nephrol; 2012 Dec 04; 25(6):989-95. PubMed ID: 22307438
    [Abstract] [Full Text] [Related]

  • 15. Comparative trial between insulin glargine and NPH insulin in children and adolescents with type 1 diabetes mellitus.
    Schober E, Schoenle E, Van Dyk J, Wernicke-Panten K, Pediatric Study Group of Insulin Glargine.
    J Pediatr Endocrinol Metab; 2002 Apr 04; 15(4):369-76. PubMed ID: 12008682
    [Abstract] [Full Text] [Related]

  • 16. Long-term efficacy of insulin glargine after switching from NPH insulin as intensive replacement of basal insulin in Japanese diabetes mellitus. Comparison of efficacy between type 1 and type 2 diabetes (JUN-LAN Study 1.2).
    Kanazawa Y, Igarashi Y, Komiya K, Sakurai Y, Shimizu T, Fujitani Y, Tanaka Y, Watada H, Kawamori R, Hirose T.
    Endocr J; 2007 Dec 04; 54(6):975-83. PubMed ID: 18000343
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Less hypoglycemia with insulin glargine in intensive insulin therapy for type 1 diabetes. U.S. Study Group of Insulin Glargine in Type 1 Diabetes.
    Ratner RE, Hirsch IB, Neifing JL, Garg SK, Mecca TE, Wilson CA.
    Diabetes Care; 2000 May 04; 23(5):639-43. PubMed ID: 10834423
    [Abstract] [Full Text] [Related]

  • 20. A one-year, randomised, multicentre trial comparing insulin glargine with NPH insulin in combination with oral agents in patients with type 2 diabetes.
    Massi Benedetti M, Humburg E, Dressler A, Ziemen M.
    Horm Metab Res; 2003 Mar 04; 35(3):189-96. PubMed ID: 12734781
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.